Lipotropic injections are commonly used as part of medical weight loss programs and can complement GLP-1 weight loss injections such as semaglutide or tirzepatide
Liraglutide for Weight Management: A Randomized, Double-Blind, Placebo-Controlled Trial
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management (weight loss and weight maintenance) in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or greater (obesity) or 27 kg/m 2 or greater (excess weight) in the presence of at least one weight related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
In triple-negative breast cancer, curcumin is noted to reinstate the expression of the tumor suppressor DLC1 by restricting the oncogene Enhancer of zeste homolog 2 (EZH2) through the reduction of Histone 3 lysine 27 trimethylation (H3K27me3) enrichment in the DLC1 promoter, consequently inhibiting the proliferation, migration, and invasion of TNBC cells while achieving apoptosis (Zhou X
Medical and Lifestyle Approaches to Ease Side Effects Over-the-counter remedies and lifestyle adjustments can significantly reduce discomfort during GLP-1 treatment